Related Experiment Video
Updated: Jun 25, 2026

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome
C De Giovanni1, G Nicoletti, A Palladini
1Cancer Research Section, Department of Experimental Pathology, Alma Mater Studiorum, University of Bologna, I-40126 Bologna, Italy. carla.degiovanni@unibo.it
Abstract:
The highly aggressive cancer syndrome of female mice carrying a p53 knockout allele and a rat HER-2/neu (Neu) transgene (BALB-p53Neu) can be prevented by a cell vaccine presenting three components: Neu, interleukin (IL)-12 production, and allogeneic major histocompatibility complex (MHC) alleles (Triplex cell vaccine). Here we tested a second-generation Triplex DNA-based vaccine (Tri-DNA), consisting of the combination of three gene components (a transmembrane-extracellular domain fragment of the Neu gene, IL-12 genes, and the H-2D(q) allogeneic MHC gene), carried by separate plasmids. The Tri-DNA vaccine was at least as effective as the Triplex cell vaccine for cancer immunoprevention, giving a similar delay in the onset of mammary cancer and complete protection from salivary cancer. Both vaccines induced anti-Neu antibodies of the murine IgG2a isotype at similar levels. The Tri-DNA vaccine gave more restricted immunostimulation, consisting of a fully helper T cell type 1 (Th1)-polarized response, with effective production of interferon (IFN)-gamma in response to the vaccine but no spontaneous production, and no induction of anti-Neu IgG3 antibodies. On the other hand, the Triplex cell vaccine induced both Th1 and Th2 cytokines, a strong increase in spontaneous IFN-gamma production, and high levels of IgG3 antibodies recognizing Neu-positive syngeneic cells. In conclusion, the Tri-DNA vaccine is as effective as Triplex cell vaccine, exploiting a more restricted immune stimulation.
Insights
A novel DNA-based cancer vaccine (Tri-DNA) effectively prevents aggressive cancers in mice. This vaccine, similar to an earlier cell-based version, offers protection by stimulating a targeted immune response against cancer cells.
Area of Science:
- Immunology
- Oncology
- Vaccine Development
Background:
- Female mice with p53 knockout and HER-2/neu (Neu) transgene develop aggressive cancer.
- A previous Triplex cell vaccine, combining Neu, IL-12, and MHC, prevented this cancer.
- A second-generation DNA-based vaccine (Tri-DNA) was developed for improved cancer immunoprevention.
Purpose of the Study:
- To evaluate the efficacy of the Tri-DNA vaccine compared to the Triplex cell vaccine.
- To analyze the immune response induced by the Tri-DNA vaccine.
- To assess the potential of Tri-DNA for cancer immunoprevention.
Main Methods:
- Developed a Tri-DNA vaccine with Neu, IL-12, and H-2D(q) MHC genes on separate plasmids.
- Administered Tri-DNA vaccine to BALB-p53Neu mice.
- Assessed cancer onset, survival rates, and immune responses (antibody isotypes, cytokine profiles).
Main Results:
- Tri-DNA vaccine demonstrated efficacy comparable to the Triplex cell vaccine.
- Both vaccines delayed mammary cancer onset and completely prevented salivary cancer.
- Tri-DNA induced a Th1-polarized immune response with IFN-gamma production and anti-Neu IgG2a antibodies.
- Triplex cell vaccine induced both Th1 and Th2 responses, increased spontaneous IFN-gamma, and IgG3 antibodies.
Conclusions:
- The Tri-DNA vaccine is as effective as the Triplex cell vaccine for cancer immunoprevention.
- Tri-DNA elicits a more restricted, Th1-biased immune stimulation.
- This suggests Tri-DNA is a promising alternative for cancer vaccine development.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Abnormal Proliferation
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
